Comparison of early and late 68Ga-FAPI-46-PET in 33 patients with possible recurrence of pancreatic ductal adenocarcinomas

被引:2
|
作者
Hoppner, Jorge [1 ]
van Genabith, Levin [1 ]
Hielscher, Thomas [2 ]
Heger, Ulrike [3 ]
Sperling, Lucas [3 ]
Colbatzky, Teresa [3 ]
Gutjahr, Ewgenija [4 ]
Lang, Matthias [3 ]
Pausch, Thomas [3 ]
Spektor, Anna-Maria [1 ]
Glatting, Frederik M. [5 ]
Liermann, Jakob [6 ]
Hackert, Thilo [3 ]
Kratochwil, Clemens [1 ]
Giesel, Frederik L. [1 ,7 ]
Haberkorn, Uwe [1 ,8 ]
Roehrich, Manuel [1 ,9 ]
机构
[1] Univ Hosp Heidelberg, Dept Nucl Med, Im Neuenheimer Feld 400, D-69120 Heidelberg, Germany
[2] German Canc Res Ctr, Dept Biostat, Heidelberg, Germany
[3] Univ Hosp Heidelberg, Dept Gen Visceral & Transplantat Surg, Heidelberg, Germany
[4] Univ Hosp Heidelberg, Dept Pathol, Heidelberg, Germany
[5] German Canc Res Ctr, Clin Cooperat Unit Mol Radiat Oncol, Heidelberg, Germany
[6] Univ Hosp Heidelberg, Dept Radiat Oncol, Heidelberg, Germany
[7] Univ Hosp Dusseldorf, Dept Nucl Med, Dusseldorf, Germany
[8] German Canc Res Ctr, Clin Cooperat Unit Nucl Med, Heidelberg, Germany
[9] Univ Hosp Mainz, Dept Nucl Med, Langenbeckstr 1, D-55131 Mainz, Germany
关键词
PET/CT; CANCER;
D O I
10.1038/s41598-023-43049-2
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Positron emission tomography with (68)Gallium (Ga-68) labeled inhibitors of fibroblast activation protein (Ga-68-FAPI-PET) is a promising imaging technique for patients with recurrent pancreatic ductal adenocarcinomas (PDAC). To date, it is not clear if different acquisition timepoints for Ga-68-FAPI-PET may result in comparable imaging information and if repetitive Ga-68-FAPI-PET imaging may add diagnostic value to single timepoint acquisition for recurrent PDAC. Here we analyzed retrospectively early (20 min p.i.) and late (60 min p.i.) Ga-68-FAPI-PET imaging using FAPI-46 of 33 patients with possible recurrence of PDAC concerning detection rates and uptake over time of local recurrences, metastases, inflammatory lesions of the pancreas, cholestatic lesions of the liver and reactive tissue. 33 patients with histologically confirmed PDAC after complete or partial resection of the pancreas and possible recurrence were examined by Ga-68-FAPI-46-PET acquired 20- and 60-min post injection (p.i.) of the radiotracer. FAPI-positive lesions were classified as local recurrences, metastases, inflammatory lesions of the pancreas (ILP), cholestatic lesions of the liver and reactive tissue based on histology, PET- and CT-morphology and clinical information. Lesions were contoured, and standardized uptake values (SUVmax and SUVmean) and target-to-background ratios (TBR) were analyzed for both acquisition timepoints. In total, 152 FAPI-positive lesions (22 local relapses, 47 metastases, 26 inflammatory lesions of the pancreas, 28 reactive tissues, and 29 cholestatic lesions) were detected. Detection rates for the early and late acquisition of Ga-68-FAPI-46-PET were almost identical except cholestatic lesions, which showed a higher detection rate at early imaging. SUV parameters and TBRs of ILP significantly decreased over time. Cholestatic lesions showed a tendency towards decreasing uptake. All other types of lesions showed relatively stable uptake over time. Early and late acquisition of Ga-68-FAPI-PET results in comparable imaging information in patients with possible recurrence of PDAC. Two timepoint imaging offers additional diagnostic potential concerning differential diagnoses.
引用
收藏
页数:11
相关论文
共 37 条
  • [1] Repetitive Early 68Ga-FAPI PET Acquisition Comparing 68Ga-FAPI-02, 68Ga-FAPI-46, and 68Ga-FAPI-74: Methodologic and Diagnostic Implications for Malignant, Inflammatory/Reactive, and Degenerative Lesions
    Glatting, Frederik M.
    Hoppner, Jorge
    Liew, Dawn P.
    van Genabith, Antonia
    Spektor, Anna-Maria
    Steinbach, Levin
    Hubert, Alexander
    Kratochwil, Clemens
    Giesel, Frederik L.
    Dendl, Katharina
    Rathke, Hendrik
    Kauczor, Hans-Ulrich
    Huber, Peter E.
    Haberkorn, Uwe
    Roehrich, Manuel
    JOURNAL OF NUCLEAR MEDICINE, 2022, 63 (12) : 1844 - 1851
  • [2] Radiation Dosimetry and Biodistribution of 68Ga-FAPI-46 PET Imaging in Cancer Patients
    Meyer, Catherine
    Dahlbom, Magnus
    Lindner, Thomas
    Vauclin, Sebastien
    Mona, Christine
    Slavik, Roger
    Czernin, Johannes
    Haberkorn, Uwe
    Calais, Jeremie
    JOURNAL OF NUCLEAR MEDICINE, 2020, 61 (08) : 1171 - 1177
  • [3] Prognostic value of preoperative [68 Ga]Ga-FAPI-04 PET/CT in patients with resectable pancreatic ductal adenocarcinoma in correlation with immunohistological characteristics
    Ding, Jie
    Qiu, Jiangdong
    Hao, Zhixin
    Huang, Hua
    Liu, Qiaofei
    Liu, Wenjing
    Ren, Chao
    Hacker, Marcus
    Zhang, Taiping
    Wu, Wenming
    Huo, Li
    Li, Xiang
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (06) : 1780 - 1791
  • [4] 68Ga-DOTA-FAPI-46 PET/CT Imaging for Restaging in a Patient With Metastatic Pheochromocytoma Comparison With 68Ga-DOTA-TATE PET/CT
    Sahin, Rahime
    Baloglu, Mehmet Can
    Ergul, Nurhan
    Cermik, Tevfik Fikret
    Arslan, Esra
    CLINICAL NUCLEAR MEDICINE, 2024, 49 (11) : e622 - e624
  • [5] Comparison of the diagnostic efficacy of 68Ga-FAPI-04 PET/MR and 18F-FDG PET/CT in patients with pancreatic cancer
    Zhang, Zeyu
    Jia, Guorong
    Pan, Guixia
    Cao, Kai
    Yang, Qinqin
    Meng, Hongyu
    Yang, Jian
    Zhang, Lu
    Wang, Tao
    Cheng, Chao
    Zuo, Changjing
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (08) : 2877 - 2888
  • [6] Comparison of the diagnostic efficacy of 68 Ga-FAPI-04 PET/MR and 18F-FDG PET/CT in patients with pancreatic cancer
    Zeyu Zhang
    Guorong Jia
    Guixia Pan
    Kai Cao
    Qinqin Yang
    Hongyu Meng
    Jian Yang
    Lu Zhang
    Tao Wang
    Chao Cheng
    Changjing Zuo
    European Journal of Nuclear Medicine and Molecular Imaging, 2022, 49 : 2877 - 2888
  • [7] A 68Ga-FAPI-46 PET/CT Imaging Pitfall in Assessing Residual Gastric Cancer Early After Chemotherapy
    af Buren, Siri
    Tran, Thuy A.
    Klevebro, Fredrik
    Holstensson, Maria
    Axelsson, Rimma
    CLINICAL NUCLEAR MEDICINE, 2022, 47 (07) : 644 - 645
  • [8] Fibroblast Activation Protein Is Overexpressed on Both Stromal and Epithelial Cells Before Pancreatic Ductal Adenocarcinoma: Implications for Early Diagnosis on 68Ga-FAPI-PET/CT
    Mcgahan, William
    Gough, Madeline
    Liu, Cheng
    Hoyte, Sharon
    Gill, Anthony j.
    Cavallucci, David
    GASTROENTEROLOGY, 2024, 167 (06) : 1217 - 1220
  • [9] [68Ga]FAPI-PET/CT for radiation therapy planning in biliary tract, pancreatic ductal adeno-, and adenoidcystic carcinomas
    Guberina, Nika
    Kessler, Lukas
    Pottgen, Christoph
    Guberina, Maja
    Metzenmacher, Martin
    Herrmann, Ken
    Mucha, Maja
    Rischpler, Christoph
    Indenkampen, Frank
    Siveke, Jens T.
    Treckmann, Jurgen
    Umutlu, Lale
    Kasper, Stefan
    Fendler, Wolfgang P.
    Stuschke, Martin
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [10] The Role of Fibroblast Activation Protein in Glioblastoma and Gliosarcoma: A Comparison of Tissue, 68 Ga-FAPI-46 PET Data, and Survival Data
    Oster, Christoph
    Kessler, Lukas
    Blau, Tobias
    Keyvani, Kathy
    Pabst, Kim M.
    Fendler, Wolfgang P.
    Costa, Pedro Fragoso
    Lazaridis, Lazaros
    Schmidt, Teresa
    Feldheim, Jonas
    Pierscianek, Daniela
    Schildhaus, Hans Ulrich
    Sure, Ulrich
    Ahmadipour, Yahya
    Kleinschnitz, Christoph
    Guberina, Nika
    Stuschke, Martin
    Deuschl, Cornelius
    Scheffler, Bjoeurorn
    Herrmann, Ken
    Kebir, Sied
    Glas, Martin
    JOURNAL OF NUCLEAR MEDICINE, 2024, 65 (08) : 1217 - 1223